ISG15: It's Complicated

被引:106
|
作者
Dzimianski, John V. [1 ]
Scholte, Florine E. M. [2 ]
Bergeron, Eric [2 ]
Pegan, Scott D. [1 ]
机构
[1] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA
[2] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA
基金
美国国家卫生研究院;
关键词
ISGylation; interferon; USP18; DUB; RIG-I; INTERFERON-STIMULATED GENE; PAPAIN-LIKE PROTEASE; UBIQUITIN-LIKE DOMAINS; EVOLUTIONARY CONSERVATION; STRUCTURAL BASIS; PRODUCT; 15; ANTIVIRAL FUNCTION; CRYSTAL-STRUCTURE; 15-KDA PROTEIN; NS1; PROTEIN;
D O I
10.1016/j.jmb.2019.03.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon-stimulated gene product 15 (ISG15) is a key component of host responses to microbial infection. Despite having been known for four decades, grasping the functions and features of ISG15 has been a slow and elusive process. Substantial work over the past two decades has greatly enhanced this understanding, revealing the complex and variable nature of this protein. This has unveiled multiple mechanisms of action that are only now beginning to be understood. In addition, it has uncovered diversity not only between how ISG15 affects different pathogens but also between the function and structure of ISG15 itself between different host species. Here we review the complexity of ISG15 within the context of viral infection, focusing primarily on its antiviral function and the mechanisms viruses employ to thwart its effects. We highlight what is known regarding the impact of ISG15 sequence and structural diversity on these interactions and discuss the aspects presenting the next frontier toward elucidating a more complete picture of ISG15 function. (C) 2019 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:4203 / 4216
页数:14
相关论文
共 50 条
  • [1] ISG15 and protein ISGylation
    Cong, Xiuli
    Reuter, Brian
    Yan, Ming
    Zhang, Dong-Er
    [J]. CYTOKINE, 2010, 52 (1-2) : 80 - 80
  • [2] ISG15: In Sickness and in Health
    Hermann, Mark
    Bogunovic, Dusan
    [J]. TRENDS IN IMMUNOLOGY, 2017, 38 (02) : 79 - 93
  • [3] ISG15 and immune diseases
    Jeon, Young Joo
    Yoo, Hee Min
    Chung, Chin Ha
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (05): : 485 - 496
  • [4] The Antiviral Activities of ISG15
    Morales, David J.
    Lenschow, Deborah J.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2013, 425 (24) : 4995 - 5008
  • [5] Antiviral Properties of ISG15
    Lenschow, Deborah J.
    [J]. VIRUSES-BASEL, 2010, 2 (10): : 2154 - 2168
  • [6] ISG15 and mycobacterial disease
    Kyle Vogan
    [J]. Nature Genetics, 2012, 44 (9) : 967 - 967
  • [7] ISG15 Deficiency: An expanding phenotype
    Sazeides, Christos
    Martin-Fernandez, Marta
    Buta, Sofija
    Milner, Joshua
    Boneparth, Alexis
    Bogunovic, Dusan
    [J]. CLINICAL IMMUNOLOGY, 2023, 250 : 131 - 131
  • [8] Ubiquitin And ISG15 Conjugation At The Ribosome
    Huibregtse, Jon
    Canadeo, Larissa
    Swaim, Caleb
    O'Connor, Hazel
    [J]. FASEB JOURNAL, 2016, 30
  • [9] ISG15 in antiviral immunity and beyond
    Yi-Chieh Perng
    Deborah J. Lenschow
    [J]. Nature Reviews Microbiology, 2018, 16 : 423 - 439
  • [10] ISG15 in antiviral immunity and beyond
    Perng, Yi-Chieh
    Lenschow, Deborah J.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2018, 16 (07) : 423 - 439